Extended Data Fig. 6: LSD1/CoREST genomic occupancy during reprogramming.
From: Endocrine resistance and breast cancer plasticity are controlled by CoREST
LSD1 ChIP-qPCR. Validation of LSD1 ChIP-seq with two different LSD1 antibodies and concentrations in parental T47D, n = 2 biological independent replicates. NANOG was used as a negative control. Validation of LSD1 ChIP-seq in reprogrammed cells. NANOG was used as a negative control. b, LSD1 ChIP-seq signal at selected genomic regions. c, LSD1 ChIP-seq peak distribution. e-f, ChIP-seq signal of biological replicates in parental and reprogrammed cells.
